Annual Report 2016 / Anti-doping Authority Netherlands (Dopingautoriteit). - Capelle aan den IJssel : Dopingautoriteit, 2017

Contents:

Chapter 1 Prevention
- General
- Elite sports
- Sports organised outside a club context
- Support staff
- Sports associations
- General public
Chapter 2 Doping controls
Chapter 3 Intelligence & Investigations
Chapter 4 Disciplinary Proceedings
Chapter 5 International Affairs
Chapter 6 Legal Affairs
Chapter 7 Scientific research
Chapter 8 Knowledge Management
Chapter 9 People & organisation

Dopingautoriteit Annual Report 2018 (Netherlands) / Anti-doping Authority Netherlands (Dopingautoriteit). - Capelle aan den IJssel : Dopingautoriteit, 2019

Contents:

Chapter 1 – Prevention
Chapter 2 – Therapeutic Use Exemptions
Chapter 3 – Doping control
Chapter 4 – Intelligence & Investigations
Chapter 5 – Disciplinary Proceedings
Chapter 6 – International Affairs
Chapter 7 – Legal Affairs
Chapter 8 – Scientific research
Chapter 9 – Knowledge management
Chapter 10 – People & organisation
--------------------------
Annex 1 - Financial overview
Annex 2 - Members of the Board of Management, Advisory Board and Committees
Annex 3 - Office staff
Annex 4 - Overview of doping control officials
Annex 5 - Overview of publications and presentations
Annex 6 - Secondary positions
Annex 7 - Abbreviations

Dopingautoriteit Annual Report 2019 (Netherlands) / Anti-doping Authority Netherlands (Dopingautoriteit). - Capelle aan den IJssel : Dopingautoriteit, 2020

Contents:

Chapter 1 – Education
Chapter 2 – Doping Control
Chapter 3 – Intelligence & Investigations
Chapter 4 – Disciplinary Proceedings
Chapter 5 – Legal Affairs
Chapter 6 – Scientific Research
Chapter 7 – Knowledge Management
Chapter 8 – Therapeutic Use Exemptions
Chapter 9 – International Affairs
Chapter 10 – People & Organisation
--------------------------
Annex 1 - Financial overview
Annex 2 - Members of the Advisory Board and Committees
Annex 3 - Office staff
Annex 4 - Overview of publications and presentations
Annex 5 - Secondary positions
Annex 6 - Abbreviations

Anti-Doping Program Annual Report (2016 & 2017) / Ethiopian National Anti-Doping Office (ETH-NADO). - Addis Ababa : ETH-NADO, 2018

Ethical aspects of doping and anti-doping : in search of an alternative policy / Bengt Kayser. - Catholic University of Leuven (KU Leuven), 2018. - Dissertation KU Leuven presented in partial fulfillment of the requirements for the degree of Doctor in Kinesiology.
- With summary in Dutch: p. ix - xii

Abstract:

The general aim of this thesis is to contribute to the discussion on doping and anti-doping, and to sketch the outlines of an alternative way of dealing with doping inside and outside of sport. After a short introduction (Chapter 1) that sketches the historical background of the main issues, an analysis of modern anti-doping in elite sport is presented, highlighting some paradoxes and weaknesses at the basis of today’s anti-doping policies (Chapter 2). Chapter 3 provides an analysis of the argument that allowing doping would merely result in a uniform shift of the playing field at the cost of greater health risks. It is shown that this is unlikely to be the case and a counterargument in favour of allowing some regulated forms of doping, because potentially leading to a more dynamic playing field, is then presented. Chapter 4 provides a perspective accounting for some of the side effects of modern anti-doping, also from a legal perspective. It highlights some of these side-effects and shows that anti-doping comes at a considerable cost to the individual athlete and the community. Chapter 5 then introduces the idea of using a harm reduction approach in the realm of doping in sport. First the principle of harm reduction is explained, building upon the evidence base in the field of recreational substance use. This is followed by a first attempt of applying its principles to doping practices in sport. Chapter 6 then takes the reasoning of the preceding chapter further by completing it with a specific analysis of the ethical implications of such a harm reduction approach for doping, concluding that such an approach can be defended. Chapter 7 finally provides a general discussion that ends with some conclusions and perspectives. The overarching conclusion of the thesis is that there is no society-wide solution to the problem of doping. Therefore practical ways of dealing with its presence aimed at containing its potential risks may represent preferable policy alternatives as compared to today’s runaway effects of globalisation of anti-doping efforts, all while promising to enrich the spectacle of modern elite sport.

Contents:

1.) Introductory remarks
2.) Current anti-doping policy: a critical appraisal
3.) What if we relaxed the anti-doping rule: towards a Red Queen effect?
4.) On the presumption of guilt without proof of intentionality and other consequences of current anti-doping policy
5.) Doping and performance enhancement: harms and harm reduction
6.) Ethics of a relaxed anti-doping rule accompanied by harm-reduction measures
7.) Discussion, conclusions and perspectives
- Appositions
- Short CV
- Publications on doping and anti-doping
- Acknowledgements, Personal contributions, Conflict of interest statement
A.) French speaking athletes’ experience and perception regarding the whereabouts reporting system and therapeutic use exemptions
B.) The anti-doping industry coming of age: in search of new markets
C.) Do public perception and the ‘spirit of sport’ justify the criminalisation of doping? A reply to Claire Sumner

In November 2016 the International Motorcycling Federation (FIM) has reported an anti-doping rule violation against the Russian rider Anastasiy Nifontova after her sample tested positive for the prohibited substance Meldonium. After notification a provisional suspension was ordered.

The Athlete demonstrated with medical evidence that the violation was not intentional because she underwent treatment for her health problems and had used prescribed medication which she mentioned on the Doping Control Form.

FIM accepts that the violation was not intentional due to the prescribed medication for a legitimate medical condition but deems that there are no grounds for No Significant Fault or Negligence.

The parties in this case reached a settlement agreement and accordingly on 13 March 2019 a 2 year period of ineligibility was imposed on the Athlete starting on the date of the provisional suspension, i.e. on 14 November 2016.

Meldonium, or mildronate / Timo Seppälä. - Helsinki : Finnish Antidoping Agency (FINADA), 2016. - 2 p., lit.

Meldonium [3-(2,2,2-trimethylhydraziniumyl)propionate; mildronate] was added to the World Anti-Doping Agency (WADA) list of prohibited substances effective 1 January 2016.
In WADA’s list of prohibited substances and methods, meldonium is listed under S4.5 ’Metabolic modulators’. These substances are prohibited at all times. They are not ’specified substances’, and their use normally carries a sanction of ineligibility of four (4) years.

In April 2016 the International Federation of Rowing Associations (FISA) has reported an anti-doping rule violation against the Athlete Serhii Budko after his sample tested positive for the prohibited substance meldonium.

After notification a provisional suspension was ordered. The Athlete submitted the FISA questionnaire without a further statement in his defence and he waived his right to be heard.

In the FISA questionnaire the Athlete stated that he had used non prescribed meldonium in March 2016 because he was feeling fatigue during training. The Athlete was not suffering from any other health condition at the time of the test and he did not mention the use of the substance on the Doping Control Form.

The FISA Doping Hearing Panel concludes that the Athlete has committed an anti-doping rule violation and decides to impose a 4 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 23 April 2016.